• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴茎癌淋巴结转移靶向成像的潜在受体

Potential Receptors for Targeted Imaging of Lymph Node Metastases in Penile Cancer.

作者信息

van der Fels Christa A M, Palthe Selma, Buikema Henk, van den Heuvel Marius C, Leliveld Annemarie, de Jong Igle Jan

机构信息

Department of Urology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.

Department of Pathology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.

出版信息

Diagnostics (Basel). 2020 Sep 15;10(9):694. doi: 10.3390/diagnostics10090694.

DOI:10.3390/diagnostics10090694
PMID:32942549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7555672/
Abstract

Imaging modalities using tumor-directed monoclonal antibodies may be of value to improve the pre- and intraoperative detection and resection of lymph node (LN) metastatic disease in penile squamous cell carcinoma (PSCC). We investigated the expression of prostate-specific membrane antigen (PSMA), vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR) and epithelial cell adhesion molecule (EpCAM) to analyze their potency for diagnostic applications. Antigen expression was determined in primary tumors and LNs with and without metastases of 22 patients with PSCC. The total immunostaining score (TIS, 0-12) was determined as the product of a proportion score (PS, 0-4) and an intensity score (IS, 0-3). EGFR and VEGF expression were high in primary tumor (median TIS 8) and LN metastases (median TIS 6 and 8, respectively). No EGFR expression was seen in LNs without metastases. However, LNs without metastases did show VEGF expression (median TIS 6). No EpCAM or PSMA expression was seen in PSCC. This study shows that VEGF and EGFR expression is moderate to high in LN metastases of PSCC. Both VEGF and EGFR warrant further clinical evaluation to determine their value as a target for pre- and intraoperative imaging modalities in the detection of LN metastases in PSCC.

摘要

使用肿瘤导向性单克隆抗体的成像方式可能有助于改善阴茎鳞状细胞癌(PSCC)中淋巴结(LN)转移疾病的术前和术中检测及切除。我们研究了前列腺特异性膜抗原(PSMA)、血管内皮生长因子(VEGF)、表皮生长因子受体(EGFR)和上皮细胞粘附分子(EpCAM)的表达,以分析它们在诊断应用中的效能。在22例PSCC患者的原发性肿瘤和有或无转移的LN中测定抗原表达。总免疫染色评分(TIS,0 - 12)被确定为比例评分(PS,0 - 4)和强度评分(IS,0 - 3)的乘积。EGFR和VEGF在原发性肿瘤(中位TIS 8)和LN转移灶(中位TIS分别为6和8)中表达较高。在无转移的LN中未见EGFR表达。然而,无转移的LN确实显示出VEGF表达(中位TIS 6)。在PSCC中未见EpCAM或PSMA表达。本研究表明,VEGF和EGFR在PSCC的LN转移灶中表达为中度至高度。VEGF和EGFR都需要进一步的临床评估,以确定它们作为PSCC中LN转移检测的术前和术中成像方式靶点的价值。

相似文献

1
Potential Receptors for Targeted Imaging of Lymph Node Metastases in Penile Cancer.阴茎癌淋巴结转移靶向成像的潜在受体
Diagnostics (Basel). 2020 Sep 15;10(9):694. doi: 10.3390/diagnostics10090694.
2
VEGF, EGFR and PSMA as possible imaging targets of lymph node metastases of urothelial carcinoma of the bladder.VEGF、EGFR 和 PSMA 可作为膀胱癌淋巴结转移的潜在影像学靶点。
BMC Urol. 2022 Dec 29;22(1):213. doi: 10.1186/s12894-022-01157-7.
3
EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.EpCAM 在膀胱尿路上皮癌淋巴结转移中的表达:一项初步研究。
Int J Mol Sci. 2017 Aug 18;18(8):1802. doi: 10.3390/ijms18081802.
4
Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma.血清LAMC2升高与阴茎鳞状细胞癌的淋巴结转移相关,并预示着预后不良。
Cancer Manag Res. 2018 Aug 28;10:2983-2995. doi: 10.2147/CMAR.S171912. eCollection 2018.
5
Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF.针对上皮细胞黏附分子的单克隆抗体用于检测前列腺癌淋巴结转移的比较:多模态对比剂的定量小动物 PET/CT 和 NIRF。
J Nucl Med. 2012 Sep;53(9):1427-37. doi: 10.2967/jnumed.112.106302. Epub 2012 Aug 7.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.前瞻性评估前列腺癌盆腔淋巴结组织学连续切片:成本效益分析。
BJU Int. 2012 Sep;110(6 Pt B):E166-71. doi: 10.1111/j.1464-410X.2012.10928.x. Epub 2012 Feb 7.
8
DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.DaPeCa - 3:前哨淋巴结活检联合(18)F - 氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在临床淋巴结阴性阴茎癌患者中的初步结果——一项来自丹麦的全国性研究
BJU Int. 2016 Jul;118(1):102-11. doi: 10.1111/bju.13243. Epub 2015 Aug 22.
9
Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.乳腺癌肿瘤相关脉管中前列腺特异性膜抗原的表达。
APMIS. 2014 Jun;122(6):482-9. doi: 10.1111/apm.12195. Epub 2013 Dec 5.
10
Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.前列腺癌患者行根治性前列腺切除术和扩大淋巴结清扫术时淋巴结转移的分布:一项联合分子与组织病理学绘图研究的结果。
Eur Urol. 2014 Aug;66(2):222-9. doi: 10.1016/j.eururo.2013.02.007. Epub 2013 Feb 18.

引用本文的文献

1
Potential of uPAR, αvβ6 Integrin, and Tissue Factor as Targets for Molecular Imaging of Oral Squamous Cell Carcinoma: Evaluation of Nine Targets in Primary Tumors and Metastases by Immunohistochemistry.uPAR、αvβ6 整联蛋白和组织因子作为口腔鳞状细胞癌分子成像靶点的潜力:免疫组织化学法评估原发肿瘤和转移灶中的九个靶点。
Int J Mol Sci. 2023 Feb 14;24(4):3853. doi: 10.3390/ijms24043853.

本文引用的文献

1
Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer.头颈部癌症患者中高级别上皮内瘤变的荧光分子成像识别。
Oral Oncol. 2019 Oct;97:50-55. doi: 10.1016/j.oraloncology.2019.08.008. Epub 2019 Aug 12.
2
Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment.VHL、HIF1A、HIF2A、VEGFA 和 p53 表达对接受舒尼替尼一线治疗的透明细胞肾细胞癌患者的预后意义。
Int J Oncol. 2019 Aug;55(2):371-390. doi: 10.3892/ijo.2019.4830. Epub 2019 Jun 25.
3
Management of the Clinically Negative (cN0) Groin Penile Cancer Patient: A Review.
临床阴性(cN0)腹股沟阴茎癌患者的管理:综述。
Urology. 2019 Sep;131:5-13. doi: 10.1016/j.urology.2019.05.005. Epub 2019 May 24.
4
Functional Characterization of VEGF- and FGF-induced Tumor Blood Vessel Models in Human Cancer Xenografts.人癌异种移植模型中VEGF和FGF诱导的肿瘤血管模型的功能特性
Anticancer Res. 2017 Dec;37(12):6629-6638. doi: 10.21873/anticanres.12120.
5
EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.EpCAM 在膀胱尿路上皮癌淋巴结转移中的表达:一项初步研究。
Int J Mol Sci. 2017 Aug 18;18(8):1802. doi: 10.3390/ijms18081802.
6
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.原发性乳腺癌患者中荧光贝伐单抗-IR-Dye800CW 微剂量的肿瘤特异性摄取:Ⅰ期可行性研究。
Clin Cancer Res. 2017 Jun 1;23(11):2730-2741. doi: 10.1158/1078-0432.CCR-16-0437. Epub 2016 Nov 9.
7
Prostate-specific Membrane Antigen-targeted Ligand Positron Emission Tomography/Computed Tomography and Immunohistochemical Findings in a Patient With Synchronous Metastatic Penile and Prostate Cancer.同步转移性阴茎癌和前列腺癌患者的前列腺特异性膜抗原靶向配体正电子发射断层扫描/计算机断层扫描及免疫组化结果
Urology. 2017 Mar;101:e5-e6. doi: 10.1016/j.urology.2016.11.040. Epub 2017 Jan 4.
8
Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis.表皮生长因子受体作为阴茎鳞状细胞癌不良生存预测指标
Hum Pathol. 2017 Mar;61:97-104. doi: 10.1016/j.humpath.2016.07.041. Epub 2016 Nov 15.
9
Current use of PSMA-PET in prostate cancer management.PSMA-PET 在前列腺癌管理中的当前应用。
Nat Rev Urol. 2016 Apr;13(4):226-35. doi: 10.1038/nrurol.2016.26. Epub 2016 Feb 23.
10
The Emerging Role and Promise of Biomarkers in Penile Cancer.生物标志物在阴茎癌中的新兴作用与前景
Urol Clin North Am. 2016 Feb;43(1):135-43. doi: 10.1016/j.ucl.2015.08.012.